Target intelligence / Profile preview

Ribosomal protein L39 pseudogene 40 (RPL39P40)

Target: RPL39P40
Molecular classification: Other, Processed pseudogene

Overview

Ribosomal protein L39 pseudogene 40 (RPL39P40) is classified as a processed pseudogene in the human genome, related by sequence similarity to the functional RPL39 gene. Pseudogenes like RPL39P40 are typically non-coding and do not produce functional proteins. There is no evidence for a biological or disease role, nor is it established as a drug target. It is primarily of genomic interest due to its sequence homology with RPL39 and many other ribosomal protein pseudogenes dispersed throughout the genome.

Other names: RPL39_21_1719

Beyond the preview

Go deeper on Ribosomal protein L39 pseudogene 40 (RPL39P40).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L39 pseudogene 40 (RPL39P40).

Explore the full profile